Mount Sinai Hospital, Mount Sinai School of Medicine, Department of Orthopaedic Surgery, New York, New York.
J Neurosurg Spine. 2013 Nov;19(5):546-54. doi: 10.3171/2013.8.SPINE12623. Epub 2013 Sep 6.
In recent years, there has been increased interest in the use of cervical disc replacement (CDR) as an alternative to anterior cervical discectomy and fusion (ACDF). While ACDF is a proven intervention for patients with myelopathy or radiculopathy, it does have inherent limitations. Cervical disc replacement was designed to preserve motion, avoid the limitations of fusion, and theoretically allow for a quicker return to activity. A number of recently published systematic reviews and randomized controlled trials have demonstrated positive clinical results for CDR, but no studies have revealed which of the 2 treatment strategies is more cost-effective. The purpose of this study was to evaluate the cost-effectiveness of CDR and ACDF by using the power of decision analysis. Additionally, the authors aimed to identify the most critical factors affecting procedural cost and effectiveness and to define thresholds for durability and function to focus and guide future research.
The authors created a surgical decision model for the treatment of single-level cervical disc disease with associated radiculopathy. The literature was reviewed to identify possible outcomes and their likelihood following CDR and ACDF. Health state utility factors were determined from the literature and assigned to each possible outcome, and procedural effectiveness was expressed in units of quality-adjusted life years (QALYs). Using ICD-9 procedure codes and data from the Nationwide Inpatient Sample, the authors calculated the median cost of hospitalization by multiplying hospital charges by the hospital-specific cost-to-charge ratio. Gross physician costs were determined from the mean Medicare reimbursement for each current procedural terminology (CPT) code. Uncertainty as regards both cost and effectiveness numbers was assessed using sensitivity analysis.
In the reference case, the model assumed a 20-year duration for the CDR prosthesis. Cervical disc replacement led to higher average QALYs gained at a lower cost to society if both strategies survived for 20 years ($3042/QALY for CDR vs $8760/QALY for ACDF). Sensitivity analysis revealed that CDR needed to survive at least 9.75 years to be considered a more cost-effective strategy than ACDF. Cervical disc replacement becomes an acceptable societal strategy as the prosthesis survival time approaches 11 years and the $50,000/QALY gained willingness-to-pay threshold is crossed. Sensitivity analysis also indicated that CDR must provide a utility state of at least 0.796 to be cost-effective.
Both CDR and ACDF were shown to be cost-effective procedures in the reference case. Results of the sensitivity analysis indicated that CDR must remain functional for at least 14 years to establish greater cost-effectiveness than ACDF. Since the current literature has yet to demonstrate with certainty the actual durability and long-term functionality of CDR, future long-term studies are required to validate the present analysis.
近年来,人们对颈椎间盘置换术(CDR)作为颈椎前路椎间盘切除融合术(ACDF)的替代疗法越来越感兴趣。虽然 ACDF 是治疗脊髓病或神经根病患者的有效方法,但它确实存在固有局限性。颈椎间盘置换术旨在保留运动功能、避免融合的局限性,并且理论上可以更快地恢复活动能力。最近发表的多项系统评价和随机对照试验显示了 CDR 的阳性临床结果,但没有研究表明这两种治疗策略中哪一种更具成本效益。本研究旨在利用决策分析的力量评估 CDR 和 ACDF 的成本效益。此外,作者旨在确定影响程序成本和效果的最关键因素,并确定耐用性和功能的阈值,以集中和指导未来的研究。
作者为单节段伴有神经根病的颈椎间盘疾病的治疗创建了一种手术决策模型。对文献进行了回顾,以确定 CDR 和 ACDF 后可能出现的结果及其可能性。健康状态效用因素从文献中确定,并分配给每个可能的结果,程序的有效性用质量调整生命年(QALY)表示。使用 ICD-9 手术代码和全国住院患者样本的数据,作者通过将医院收费乘以医院特定的收费与收费比来计算住院费用的中位数。总医师费用是根据每个当前程序术语(CPT)代码的 Medicare 报销平均值确定的。使用敏感性分析评估成本和效果数字的不确定性。
在参考案例中,该模型假设 CDR 假体的使用寿命为 20 年。如果两种策略都能持续 20 年,颈椎间盘置换术导致的平均 QALY 获益更高,且对社会的成本更低(CDR 为 3042/QALY,ACDF 为 8760/QALY)。敏感性分析显示,CDR 必须至少存活 9.75 年才能被认为比 ACDF 更具成本效益。随着假体生存时间接近 11 年,并且越过 50000 美元/QALY 的意愿支付阈值,颈椎间盘置换术成为一种可接受的社会策略。敏感性分析还表明,CDR 必须提供至少 0.796 的效用状态才能具有成本效益。
在参考案例中,CDR 和 ACDF 均被证明是具有成本效益的手术。敏感性分析结果表明,CDR 必须至少保持 14 年的功能,才能比 ACDF 更具成本效益。由于目前的文献尚未确定颈椎间盘置换术的实际耐用性和长期功能,因此需要进行未来的长期研究来验证本分析。